Search by Drug Name or NDC
NDC 11673-0192-03 STOOL SOFTENING SENNA LAXATIVE 50; 8.6 mg/1; mg/1 Details
STOOL SOFTENING SENNA LAXATIVE 50; 8.6 mg/1; mg/1
STOOL SOFTENING SENNA LAXATIVE is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by TARGET CORPORATION. The primary component is DOCUSATE SODIUM; SENNOSIDES A AND B.
MedlinePlus Drug Summary
Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.
Related Packages: 11673-0192-03Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Senna
Stool softeners are used on a short-term basis to relieve constipation by people who should avoid straining during bowel movements because of heart conditions, hemorrhoids, and other problems. They work by softening stools to make them easier to pass.
Related Packages: 11673-0192-03Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Stool Softeners
Product Information
| NDC | 11673-0192 |
|---|---|
| Product ID | 11673-192_81f51705-1b12-f726-e053-2991aa0a8e02 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | STOOL SOFTENING SENNA LAXATIVE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | SENNOSIDES 8.6 MG - DOCUSATE SODIUM 50 MG |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 50; 8.6 |
| Active Ingredient Units | mg/1; mg/1 |
| Substance Name | DOCUSATE SODIUM; SENNOSIDES A AND B |
| Labeler Name | TARGET CORPORATION |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Listing Certified Through | 2024-12-31 |
Package
Package Images
NDC 11673-0192-03 (11673019203)
| NDC Package Code | 11673-192-03 |
|---|---|
| Billing NDC | 11673019203 |
| Package | 30 TABLET in 1 BOTTLE (11673-192-03) |
| Marketing Start Date | 2019-03-29 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 7c74bd91-6687-2b89-e053-2a91aa0ad6b8 Details
INACTIVE INGREDIENTS
| INACTIVE INGREDIENTS: carnauba wax, colloidal silicon dioxide, croscarmellose sodium, dibasic calcium phosphate dihydrate, d-c yellow#10 aluminum lake, fd&c yellow#6 aluminum lake, Hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium benzoate, stearic acid, titanium dioxide |
INDICATIONS AND USAGE
DOSAGE AND ADMINISTRATION
|
Directions: Take preferably at bedtime or as directed by a doctor. If you do not have a comfortable bowel movement by the second day, increase dose by one tablet (not to exceed maximum dosage) or decrease dose until you are comfortable. Adults and children 12 years and older: - Starting dosage: 2 tablets once a day - Maximum dosage: 4 tablets twice a day Children 6 to under 12 years: - Starting dosage: 1 tablet once a day-Maximum dosage: 2 tablets twice a day Children 2 to under 6 years - Starting dosage: 1/2 tablet once a day- Maximum dosage: 1 tablet twice a day Children under 2 years - Ask a doctor |
WARNINGS
KEEP OUT OF REACH OF CHILDREN
INGREDIENTS AND APPEARANCE
| STOOL SOFTENING SENNA LAXATIVE
sennosides 8.6 mg - docusate sodium 50 mg tablet |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Labeler - TARGET CORPORATION (006961700) |
| Registrant - TIME CAP LABORATORIES, INC. (037052099) |
| Establishment | |||
| Name | Address | ID/FEI | Business Operations |
|---|---|---|---|
| TIME CAP LABORATORIES, INC | 037052099 | manufacture(11673-192) | |